Loading...

Drugs Made In America Acquisition Corp. Units

DMAAU•NASDAQ
Financial Services
Financial - Conglomerates
$10.97
$0.39(3.73%)
U.S. Market opens in 12h 28m

Drugs Made In America Acquisition Corp. Units (DMAAU) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Drugs Made In America Acquisition Corp. Units (NASDAQ:DMAAU).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

DMAAU Technical Analysis Summary

Drugs Made In America Acquisition Corp. Units stock currently shows a bullish trend, supported by momentum and strong buying pressure.

Overall Sentiment:Buy
Momentum:Neutral to Bullish (RSI: 56.85)
Trend Strength:Very Strong (ADX: 96.02)
Volatility:Medium (ATR: 0.34)
Support/Resistance:$10.47 – $10.62 (Bollinger Bands)

Technical conditions suggest Drugs Made In America Acquisition Corp. Units is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 56.85

Bullish
Above midpoint suggests upward bias.

Stochastic %K: 97.85

Bearish
Overbought levels may trigger pullback.

Williams %R: -6.25

Bearish
Overbought levels may trigger correction.

Rate of Change (ROC): 0.28

Neutral
Price change is minimal.

Takeaway:Drugs Made In America Acquisition Corp. Units shows strong bullish momentum, with buyers firmly in control.

Trend & Volatility

MACD: 0.01

Bullish
Bullish, trend momentum is strengthening.

ADX: 96.02

Very Strong
Very strong trend, powerful directional momentum.

ATR (14): 0.34

Low
Low volatility, stable price action.

CCI (14): 68.36

Bullish
Bullish, momentum building upward.

Takeaway:Drugs Made In America Acquisition Corp. Units shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators
Bollinger Bands
Upper Band
$10.62
Middle Band (SMA 20)
$10.55
Lower Band
$10.47
Current Position
Above Upper Band

Takeaway:Drugs Made In America Acquisition Corp. Units trades near the upper band, signaling overbought conditions and risk of pullback.

Keltner Channels
Upper Channel
$11.22
Middle Line (EMA 20)
$10.55
Lower Channel
$9.87
Squeeze Status
Squeeze On

Takeaway:Drugs Made In America Acquisition Corp. Units trades above the trend line, showing healthy momentum within the channel.

Volume & Money Flow Analysis
On-Balance Volume4.12K
Money Flow Index96.23Bearish risk, overbought conditions may trigger pullback.
Relative Vigor Index14.68Bearish, price momentum favors sellers.

Overall Takeaway:DMAAU shows mixed signals in money flow analysis.

Technical Trading Signals Summary
Based on the current technical analysis of Drugs Made In America Acquisition Corp. Units, here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

ADX above 20 → strong underlying trend.

Price trading above middle Bollinger Band → mid-term support intact.

Bearish Signals

Price near upper Bollinger Band → potential resistance and pullback risk.

MFI above 80 → overbought conditions may limit upside.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Drugs Made In America Acquisition Corp. Units currently shows a Buy with caution signal — momentum and trend strength are positive, but price is close to resistance and may face short-term pullbacks.

Technical Analysis FAQ